Polio Set To get The Nanopatch Treatment from Vaxxas

Vaxxas announces a WHO funded project to evaluate the delivery of polio vaccine using Nanopatch Australian company Vaxxas last week announced the initiation of a research project designed to evaluate the commercialisation prospects of Nanopatch, their microneedle platform for the delivery of polio vaccine. Vaxxas’ Nanopatch consists of a 1cm2 square of silicon with around 20,000 microprojections on its surface. Penetrating …

Self-Administration of Flu Vaccine with a Patch May be Feasible

February 26, 2014 The annual ritual of visiting a doctor’s office or health clinic to receive a flu shot may soon be outdated, thanks to the findings of a new study published in the journal Vaccine. The research, which involved nearly 100 people recruited in the metropolitan Atlanta area, found that test subjects could successfully apply a prototype vaccine patch to …